TY  - JOUR
AU  - Masebo, Lehané
AU  - Whitfield, Tim
AU  - Demnitz-King, Harriet
AU  - Heslegrave, Amanda
AU  - Poisnel, Géraldine
AU  - Lutz, Antoine
AU  - Frison, Eric
AU  - Wirth, Miranka
AU  - Hye, Abdul
AU  - Jessen, Frank
AU  - Ashton, Nicholas J.
AU  - Zetterberg, Henrik
AU  - Marchant, Natalie L.
TI  - Can non-pharmacological interventions change levels of neurofilament light in older adults at risk of dementia? A secondary analysis of the SCD-Well randomized clinical trial
JO  - The journal of prevention of Alzheimer's disease
VL  - 12
IS  - 8
SN  - 2274-5807
CY  - Cham
PB  - Springer International Publishing
M1  - DZNE-2025-00895
SP  - 100299
PY  - 2025
AB  - Older adults with subjective cognitive decline (SCD) and/or elevated neurofilament light (NfL), a neurodegeneration biomarker, are at increased risk of dementia. Non-pharmacological interventions offer a promising strategy for reducing dementia risk, yet none have utilized NfL as a marker of response in dementia prevention trials.To investigate the effects of two non-pharmacological interventions on NfL in older adults with SCD.SCD-Well was an 8-week observer-blinded, randomized, clinical trial with 6-month follow-up, and was a part of the Horizon 2020 European Union-funded 'Medit-Ageing' project. Data were analyzed from June 2022 to August 2024.Memory clinics at four sites in France, Germany, Spain, and UK.Participants were enrolled from March 2017 to January 2018 after fulfilling SCD research criteria and performing within the normal range on cognitive testing. Of the 147 participants enrolled, 140 were included in this secondary analysis (7 did not consent to venipuncture).Participants were randomly allocated to the Caring Mindfulness-Based Approach for Seniors (CMBAS) intervention or a structurally matched Health Self-Management Program (HSMP).Plasma NfL was measured at baseline (V1), post-intervention (V2), and 6-month follow-up (V3), using Single molecule array technology, and log-transformed for analyses.137 older adults with SCD provided NfL data (mean [SD] age: 72.7 [6.8] years; 62.0 
KW  - Behavior change (Other)
KW  - Blood (Other)
KW  - Blood-based biomarkers (Other)
KW  - Fluid biomarkers (Other)
KW  - Psychological intervention (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:40683836
DO  - DOI:10.1016/j.tjpad.2025.100299
UR  - https://pub.dzne.de/record/280058
ER  -